1Francesco Montagnani,Gina Turrisi,Claudio Marinozzi,Camillo Aliberti,Giammaria Fiorentini.Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis[J]. Gastric Cancer . 2011 (1) 被引量：2
2Y. S. Hong,S. Y. Song,S. I. Lee,H. C. Chung,S. H. Choi,S. H. Noh,J. N. Park,J. Y. Han,J. H. Kang,K. S. Lee,J. Y. Cho.A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer[].Annals of Oncology.2004 被引量：1
3Louvet C,Andre T,Tigaud J M,et al.PhaseⅡ study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. Journal of Clinical Oncology . 2002 被引量：2
4Thuss-Patience PC,Kretzschmar A,Dogan Y,et al.Capecitabine and docetaxel for advanced gastric cancer. Journal of Clinical Oncology . 2006 被引量：1
5De Vita F,Orditura M,Matano E,et al.A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. British Journal of Cancer . 2005 被引量：1
6Kondo K,Chin K, et al.A multicenter phase II trial using 4-week cycles of capecitabine in advanced/metastatic gastric cancer (AGC). Proceedings of the American Society of Clinical Oncology . 2003 被引量：1
3LEE J, PARK CK, PARK JO, et al. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy[ J]. Clin Cancer Res, 2008,14 ( 1 ) : 82-88. 被引量：1
4MONRERO E, ABREU C, TONINO P, et al. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas [ J ]. J Cancer Res Clin Oncol, 2008, 134(2) :193-201. 被引量：1
5LIN S Z, TONG H F, YOU T, et al. Palliative gastrectomy and chemotherapy for stage IV gastric cancer [ J ]. J Cancer Res Clin Oncol, 2008, 134(2) :187-192. 被引量：1
6ROTH A D, FAZIO N, STUPP R, et al. Docetaxel, cisplatin,and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research[ J]. J Clin Oncol, 2007, 25 (22):3217- 3223. 被引量：1
7CHIESA MD, BUTI S, TOMASELLO G, et al. A pilot phase Ⅱ study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer[ J]. Tumor, 2007, 93 ( 3 ) :244-247. 被引量：1
8M ARUTA F, ISHIZONE S, HIRAGURI M,et al. A clinical study of docetaxel with or without 5' DFUR as a second-line chemotherapy for advanced gastric cancer [ J ]. Med Oncol, 2007, 24 ( 1 ) : 71- 75. 被引量：1
9NERI B, PANTALEO P, GIOMMONI E, et al. Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase Ⅱ study [ J]. Br J Cancer, 2007, 96(7 ) : 1043-1046. 被引量：1
10KIM D , JOO J K, RYU SY, et al. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia [ J ]. Dig Surg, 2006, 23(5-6):313-318. 被引量：1
